Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility-Reference-Cited by-同舟云学术

Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility

Published:2022-05-18 Issue:7 Volume:18 Page:400-418
ISSN:1759-4758
Container-title:Nature Reviews Neurology
language:en
Short-container-title:Nat Rev Neurol

Author:

Karikari Thomas K.^ORCID,Ashton Nicholas J.^ORCID,Brinkmalm Gunnar,Brum Wagner S.,Benedet Andréa L.,Montoliu-Gaya Laia^ORCID,Lantero-Rodriguez Juan^ORCID,Pascoal Tharick Ali^ORCID,Suárez-Calvet Marc^ORCID,Rosa-Neto Pedro^ORCID,Blennow Kaj^ORCID,Zetterberg Henrik^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Neurology (clinical)

Link

https://www.nature.com/articles/s41582-022-00665-2.pdf

Reference179 articles.

1. Hippius, H. & Neundörfer, G. The discovery of Alzheimer’s disease. Dialogues Clin. Neurosci. 5, 101–108 (2003).

2. Alzheimer’s Association. 2020 Alzheimer’s disease facts and figures. Alzheimers Dement. 16, 391–460 (2020).

3. Prince, M. et al. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement. 9, 63–75 (2013).

4. Nichols, E. et al. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 18, 88–106 (2019).

5. GBD 2019 Dementia Forecasting Collaborators Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7, e105–e125 (2022).

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA;Neurobiology of Aging;2024-11

2. Alzheimer’s disease biomarkers and their current use in clinical research and practice;Molecular Psychiatry;2024-09-04

3. Updates in Alzheimer's disease: from basic research to diagnosis and therapies;Translational Neurodegeneration;2024-09-04

4. A novel plasma p-tau181 assay as a specific biomarker of tau pathology in Alzheimer's disease;Translational Neurodegeneration;2024-09-03

5. Rationale and design of the BeyeOMARKER study: prospective evaluation of blood- and eye-based biomarkers for early detection of Alzheimer’s disease pathology in the eye clinic;Alzheimer's Research & Therapy;2024-08-21